Article
Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.
Progress in neuro-psychopharmacology & biological psychiatry - 30 Apr 2009
Chen Shih-Fen, Shen Yu-Chih, Chen Chia-Hsiang
Abstract excerpt
Aripiprazole, a novel antipsychotic agent, has a unique pharmacological action (partial agonist) on the dopamine neurotransmission system. Aripiprazole has high affinity for dopamine D2 and D3 receptors (DRD2 and DRD3). We investigated whether the efficacy of aripiprazole can be predicted by a functional DRD3 gene polymorphism Ser9Gly (rs6280) as modified by clinical factors in Han Chinese hospitalized patients...
Topics
- Adult
- Analysis of Variance
- Antipsychotic Agents
- Aripiprazole
- Female
- Genotype
- Glycine
- Humans
- Male
